Asian Stocks Mixed in March 2026 Amid Iran War Fears and Tech Selloff 
Oil Prices Climb as Middle East Conflict Keeps Supply Risks Elevated 
Oil Prices Hold Near Multi-Year Highs Amid Iran Conflict and Hormuz Supply Fears 
Oil Prices Dip as Trump Eyes Iran De-escalation, Hormuz Closure Persists 
China Manufacturing PMI Hits 12-Month High Amid Energy Price Concerns 
WTO Ministerial Collapse Leaves Global Digital Trade Rules in Limbo 
Asian Currencies Hold Steady Amid U.S.-Israel-Iran Tensions and BOJ Signals 
Bessent: Global Oil Market Well Supplied as U.S. Eyes Hormuz Navigation Control 
Dollar Surges to Nine-Month High as Middle East Tensions Drive Safe-Haven Demand 
Oil Prices Surge to Record Monthly Highs as Middle East War Rattles Global Markets 
Japan's Business Confidence Rises Despite Iran War Uncertainty, BOJ Rate Hike Expected 
U.S. Trade Rep Dismisses WTO's Future Role After Failed Cameroon Summit 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
U.S. Stock Futures Surge After WSJ Report on Trump's Iran War Exit Strategy 
Bank of Korea Nominee Shin Hyun-song Calls for Flexible Monetary Policy Amid Iran War Risks 
South Korea Manufacturing PMI Hits 4-Year High in March 2025 Driven by Semiconductor Demand 
Japan Business Sentiment Rises as Iran War Fuels Inflation Fears, BOJ Rate Hike Looms 
Starboard Value’s Investment in Kenvue Inc.
Activist hedge fund Starboard Value has taken a "sizeable" stake in Kenvue Inc., according to *The Wall Street Journal*. While the exact percentage of the investment is undisclosed, Starboard is pushing for changes aimed at boosting Kenvue's stock price. Kenvue, which was spun off from Johnson & Johnson in 2023, has seen its stock underperform both its industry peers and the broader market since its debut.
Kenvue’s Strong Consumer Brands
Kenvue boasts several well-known consumer brands, such as Tylenol, Listerine, and Band-Aid. Despite its strong portfolio, Kenvue's stock performance has been relatively muted in 2024, while the S&P 500 has surged by 24%. Starboard believes that these valuable brands are not yet reflected in the company’s current valuation.
Starboard’s Broader Strategy
This is not the first major move by Starboard Value. The hedge fund, led by CEO Jeff Smith, recently acquired a $1 billion stake in pharmaceutical giant Pfizer and has been involved in advocating for changes at tech companies like Salesforce, Autodesk, and Match Group.
